Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,346Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Alembic Pharmaceuticals Limited

02 3MSN Laboratories

03 10Pfizer Inc

04 3Sun Pharmaceutical Industries Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB MONOHYDRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2025-05-23

Application Number : 209543

Regulatory Info : RX

Registration Country : USA

blank

02

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB MONOHYDRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2025-05-23

Application Number : 209543

Regulatory Info : RX

Registration Country : USA

blank

03

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number : 209624

Regulatory Info :

Registration Country : USA

blank

04

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date :

Application Number : 209624

Regulatory Info :

Registration Country : USA

blank

05

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date :

Application Number : 209624

Regulatory Info :

Registration Country : USA

blank

06

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2012-09-04

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

07

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2012-09-04

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

08

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE

Packaging :

Approval Date : 2017-10-27

Application Number : 203341

Regulatory Info : RX

Registration Country : USA

blank

09

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date : 2023-09-26

Application Number : 217729

Regulatory Info : RX

Registration Country : USA

blank

10

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSULIF

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2023-09-26

Application Number : 217729

Regulatory Info : RX

Registration Country : USA

blank

11

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Bosutinib Monohydrate

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 500MG

Packaging :

Approval Date : 2013-04-24

Application Number : 113818003

Regulatory Info : Authorized

Registration Country : Spain

blank

12

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Bosutinib Monohydrate

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG

Packaging :

Approval Date : 2018-06-05

Application Number : 113818006

Regulatory Info : Authorized

Registration Country : Spain

blank

13

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

Bosutinib Monohydrate

Brand Name : Bosulif

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2013-04-24

Application Number : 113818001

Regulatory Info : Authorized

Registration Country : Spain

blank

14

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB (BOSUTINIB MONOHYDRATE)

Brand Name : BOSULIF

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 28/120

Approval Date :

Application Number : 2419149

Regulatory Info : Prescription

Registration Country : Canada

blank

15

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB (BOSUTINIB MONOHYDRATE)

Brand Name : BOSULIF

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging : 28/30

Approval Date :

Application Number : 2419157

Regulatory Info : Prescription

Registration Country : Canada

blank

16

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number : 209577

Regulatory Info :

Registration Country : USA

blank

17

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date :

Application Number : 209577

Regulatory Info :

Registration Country : USA

blank

18

DDL Conference
Not Confirmed
arrow
arrow
DDL Conference
Not Confirmed

BOSUTINIB MONOHYDRATE

Brand Name : BOSUTINIB

Dosage Form : TABLET;FILM COATED

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date :

Application Number : 209577

Regulatory Info :

Registration Country : USA

blank